United States:
DOJ Issues Antitrust Guidance On Competitor Collaboration To Combat COVID-19
18 April 2020
McDermott Will & Emery
To print this article, all you need is to be registered or login on Mondaq.com.
The US Department of Justice (DOJ) Antitrust Division issued a
business review
letter that underscores the flexibility of the US antitrust
regulators towards competitor collaborations aimed at increasing
the supply and distribution of medical equipment needed to fight
the Coronavirus (COVID-19) pandemic. This letter can provide
guidance to other companies considering collaborations to assist in
the response to COVID-19.
Access full article.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Antitrust/Competition Law from United States
US Antitrust Agencies Release Final Revised Merger Guidelines
Goodwin Procter LLP
On December 18, 2023, the Federal Trade Commission and the Antitrust Division of the Department of Justice released the final version of revised Merger Guidelines, a set of principles Agencies use in their review of mergers and acquisitions.
